Compare AVAH & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVAH | AXGN |
|---|---|---|
| Founded | 1984 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2021 | 2013 |
| Metric | AVAH | AXGN |
|---|---|---|
| Price | $11.01 | $55.96 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | $15.20 | ★ $60.09 |
| AVG Volume (30 Days) | ★ 2.1M | 2.0M |
| Earning Date | 11-12-2026 | 10-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1850.00 | N/A |
| EPS | ★ 0.57 | N/A |
| Revenue | ★ $2,433,199,000.00 | $225,208,000.00 |
| Revenue This Year | $11.36 | $28.92 |
| Revenue Next Year | $7.58 | $28.37 |
| P/E Ratio | $18.81 | ★ N/A |
| Revenue Growth | 20.19 | ★ 20.21 |
| 52 Week Low | $5.93 | $26.92 |
| 52 Week High | $14.71 | $59.72 |
| Indicator | AVAH | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 31.53 | 66.73 |
| Support Level | $8.91 | $39.18 |
| Resistance Level | $13.76 | $59.72 |
| Average True Range (ATR) | 0.71 | 2.93 |
| MACD | -0.28 | 0.30 |
| Stochastic Oscillator | 11.22 | 68.56 |
Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). The Private Duty Services segment generates the majority of revenue, which includes private duty skilled nursing services, non-clinical and personal care services, and pediatric therapy services, and is principally reimbursed by Medicaid and Medicaid MCO.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.